Diabetes affects millions worldwide, and while it's primarily known for disrupting blood sugar regulation, its impact extends ...

Shares of Kodiak Sciences (KOD) rallied 32% Monday after Jefferies upgraded the stock to buy from hold, citing the company’s turnaround and upcoming catalysts. Read more here.

in spite of the fact that current treatments are effective. Vision loss occurs in DR due to the development of maculopathy, especially diabetic macular edema, and due to proliferative diabetic ...

Jefferies Financial Group upgraded shares of Kodiak Sciences (NASDAQ:KOD – Free Report) from a hold rating to a buy rating in a research report sent to investors on Monday morning, Marketbeat.com ...

Abnormalities of the vitreoretinal interface may contribute to important retinal pathologies such as diabetic retinopathy, diabetic macular edema and ... The only treatment option currently ...

Ahead of this year's Floretina meeting and International Congress on OCT Angiography, En Face OCT and Advances in OCT (ICOOR), David Hutton of Ophthalmology Times spoke with Charles Wykoff, MD, PhD.

Ahead of this year's Floretina meeting and International Congress on OCT Angiography, En Face OCT and Advances in OCT (ICOOR), David Hutton of Ophthalmology Times spoke with Charles Wykoff, MD, PhD.

In a report released on December 3, Julian Harrison from BTIG maintained a Buy rating on Rezolute (RZLT – Research Report), with a price target ...

Leerink Partners analyst Joseph Schwartz maintained a Buy rating on KalVista Pharmaceuticals (KALV – Research Report) on December 6 and set a ...

An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of ...

Real-World Indian Data Confirms Safety of Lupin's Ranieyes for various Chorioretinal Vascular Disease Ranibizumab (Ranieyes) ...

By far, the largest acquisition of 2024 was Novo Holdings' yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion.